Non-small cell lung cancer tumour antigen, MUC-1 peptide-loaded non-aggregated poly (lactide-co-glycolide) nanoparticles augmented cellular uptake in mouse professional antigen-presenting cells: optimisation and characterisation

References

• Acharya, S., Dilnawaz, F., and Sahoo, S.K., 2009. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 30(29), 5737–5750.
   PubMed Web of Science ®Google Scholar
• Aggarwal, S., et al., 2013. Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapyof pancreatic cancer. Cancer nanotechnology, 4(6), 145–157.
   PubMedGoogle Scholar
• Ai, X., et al., 2018. Targeted therapies for advanced non-small cell lung cancer. Oncotarget, 9(101), 37589–37607.
   PubMedGoogle Scholar
• Siegel, R.L., Miller, K,D., and Jemal, A., 2019. Cancer statistics. CA Cancer Journal of Clinicians, 69 (1), 7–34.
   PubMed Web of Science ®Google Scholar
• Beck-Schimmer, B., et al., 2005. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respiratory research, 6(1), 61.
   PubMed Web of Science ®Google Scholar
• Bolhassani, A., Safaiyan, S., and Rafati, S., 2011. Improvement of different vaccine delivery systems for cancer therapy. Molecular cancer, 10(1), 3.
   PubMed Web of Science ®Google Scholar
• Butts, C., et al., 2005. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. Journal of clinical oncology, 23(27), 6674–6691.
   PubMed Web of Science ®Google Scholar
• Caddeo, C., et al., 2015. Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging. International journal of pharmaceutics, 484(1-2), 138–145.
   PubMed Web of Science ®Google Scholar
• Chen, H., et al., 2014. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug discovery today, 4, 502–509.
   Web of Science ®Google Scholar
• Chithrani, B.D., Ghazani, A.A., and Chan, W.C., 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano letters, 6(4), 662–668.
   PubMed Web of Science ®Google Scholar
• Cho, H.J., et al., 2013. Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function. Journal of pharmacy and pharmacology, 65(10), 1440–1450.
   PubMed Web of Science ®Google Scholar
• Cocucci, E., et al., 2012. The first five seconds in the life of a clathrin-coated pit. Cell, 150(3), 495–507.
   PubMed Web of Science ®Google Scholar
• Cooper, D.L. and Harirforoosh, S., 2014. Design and optimization of PLGA-based diclofenac loaded nanoparticles. PLoS one , 9(1), e87326.
   PubMed Web of Science ®Google Scholar
• Croce, M.V., et al., 2001. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast cancer research and treatment, 69(1), 1–11.
   PubMed Web of Science ®Google Scholar
• D’Errico, G., Machado, H.L., and Sainz Jr, B., 2017. A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet. Clinical and translational medicine, 6, 3.
   PubMed Web of Science ®Google Scholar
• Demento, S.L., et al., 2012. Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. Biomaterials, 33(19), 4957–4964.
   PubMed Web of Science ®Google Scholar
• Długońska, H. and Grzybowski, M., 2012. Mucosal vaccination–an old but still vital strategy. Annals of parasitology, 58(1), 1–8.
   PubMedGoogle Scholar
• Ferlay, J., et al., 2013., Globocan, cancer incidence and mortality worldwide. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Foged, C., et al., 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. International journal of pharmaceutics, 298(2), 315–322.
   PubMed Web of Science ®Google Scholar
• Ford, M.G., et al., 2002. Curvature of clathrin-coated pits driven by epsin. Nature, 419(6905), 361–366.
   PubMed Web of Science ®Google Scholar
• Geiser, M., et al., 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxideparticles. American journal of respiratory cell and molecular biology, 38(3), 371–376.
   PubMed Web of Science ®Google Scholar
• Gratton, S.E., et al., 2008. The effect of particle design on cellular internalization pathways. Proceedings of the national academy of sciences, 105(33), 11613–11618.
   PubMed Web of Science ®Google Scholar
• Grindel, J.M., et al., 2002. Distribution, metabolism, and excretion of a novel surface‐active agent, purified poloxamer 188, in rats, dogs, and humans. Journal of pharmaceutical sciences, 91, 1936–1947.
   PubMed Web of Science ®Google Scholar
• Guan, H.H., et al., 1998. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Bioconjugate chemistry, 9(4), 451–458.
   PubMed Web of Science ®Google Scholar
• Hardy, C.L., et al., 2013. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. The journal of immunology, 191(10), 5278–5790.
   PubMed Web of Science ®Google Scholar
• He, W., et al., 2003. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infection and immunity, 71(2), 930–936.
   PubMed Web of Science ®Google Scholar
• Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 68 (6), 394–424.
   PubMed Web of Science ®Google Scholar
• Italia, J.L., et al., 2007. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. Journal of controlled release, 119(2), 197–206.
   PubMed Web of Science ®Google Scholar
• Jackman, D.M. and Johnson, B.E., 2005. Small-cell lung cancer. The lancet, 366(9494), 1385–1396.
   PubMed Web of Science ®Google Scholar
• Jyoti, K., et al., 2015. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies. Journal of colloid and interface science, 445, 219–230.
   PubMed Web of Science ®Google Scholar
• Kaur, A., et al., 2016. Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses. Journal of microencapsulation, 33(3), 263–273.
   PubMed Web of Science ®Google Scholar
• Khun, D.A., et al., 2014. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein journal of nanotechnology, 5, 1625–1636.
   PubMed Web of Science ®Google Scholar
• Kirchhausen, T., 2000. Clathrin. Annual review of biochemistry, 69(1), 699–727.
   PubMed Web of Science ®Google Scholar
• Krzysiek, R., et al., 1999. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. The Journal of immunology : official journal of the American Association of Immunologists, 162(8), 4455–4463.
   Google Scholar
• Kufe, D., et al., 1984. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma, 3(3), 223–232.
   PubMedGoogle Scholar
• Lee, H., et al., 2019. Dendritic cell-targeted pH-responsive extracellular vesicles for anticancer vaccination. Pharmaceutics, 11(2), 54.
   PubMed Web of Science ®Google Scholar
• Ma, W., et al., 2012. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. International journal of nanomedicine, 7, 1475–1487.
   PubMed Web of Science ®Google Scholar
• Made, V., Els-Heindl, S., and Beck-Sickinger, A.G., 2014. Automated solid-phase peptide synthesis to obtain therapeutic peptides. Beilstein journal of organic chemistry, 10, 1197.
   PubMed Web of Science ®Google Scholar
• Malik, A., et al., 2018. Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax. Frontiers in immunology, 9, 562.
   PubMed Web of Science ®Google Scholar
• Marsh, M. and McMahon, H.T., 1999. The structural era of endocytosis. Science, 285(5425), 215–220.
   PubMed Web of Science ®Google Scholar
• Martin-Munoz, M.F., et al., 2002. Anaphylactic reaction to diphtheria-tetanus vaccine in a child: specific IgE/IgG determinations and cross-reactivity studies. Vaccine, 20, 3409–3412.
   PubMed Web of Science ®Google Scholar
• Matsuo, K., et al., 2011. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. Journal of controlled release, 152(2), 310–316.
   PubMed Web of Science ®Google Scholar
• McMahon, H.T. and Boucrot, E., 2011. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nature reviews molecular cell biology, 12(8), 517–533.
   PubMed Web of Science ®Google Scholar
• Micsonai, A., et al., 2015. Accurate secondary structure prediction and fold recognition for circular dichroismspectroscopy. Proceedings of the National Academy of Sciences of the United States of America, 112(24), E3095–103.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, A., Dyring, C., and Stott, D.I., 2014. Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer. Vaccine, 32(8), 1012–1018.
   PubMed Web of Science ®Google Scholar
• Nembrini, C., et al., 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proceedings of the National Academy of Sciences of the United States of America, 108, 17867–17868.
   Web of Science ®Google Scholar
• Ng, C.T., et al., 2015. Clathrin-mediated endocytosis of gold nanoparticles in vitro. The anatomical record, 298(2), 418–427.
   Google Scholar
• Otaka, A., Sato, K., and Shigenaga, A., 2015. Chemical synthesis of proteins using N-sulfanylethylanilide peptides, based on N-S acyl transfer chemistry. Topics in current chemistry, 363, 33–56.
   PubMed Web of Science ®Google Scholar
• Perepelyuk, M., et al., 2018. Evaluation of MUC1-Aptamer functionalized hybrid nanoparticles for targeted delivery of miRNA-29b to non small cell lung cancer. Molecular pharmaceutics, 15(3), 985–993.
   PubMed Web of Science ®Google Scholar
• Peter, B.J., et al., 2004. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science, 303(5657), 495–499.
   PubMed Web of Science ®Google Scholar
• Qiu, Y., et al., 2010. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials, 31(30), 7606–7619.
   PubMed Web of Science ®Google Scholar
• Ranoszek-Soliwoda, K., et al., 2017. Catalase-modified gold nanoparticles: determination of the degree of protein adsorption by gel electrophoresis. Colloids and surfaces B: biointerfaces, 159, 533–539.
   PubMed Web of Science ®Google Scholar
• Saez, A., et al., 2000. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European journal of pharmaceutics and biopharmaceutics, 50(3), 379–387.
   PubMed Web of Science ®Google Scholar
• Saini, J., et al., 2014. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids and surfaces B: biointerfaces, 118, 101–110.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, Y., et al., 2019. Effects of Cu2+ on conformational change and aggregation of hPrP180-192 with a V180I mutation of the prion protein. Biochemical and biophysical research communications, 514(3), 798–802.
   PubMed Web of Science ®Google Scholar
• Sangha, R. and Butts, C., 2007. L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 13, 4652–4654.
   PubMed Web of Science ®Google Scholar
• Schmid, E.M. and McMahon, H.T., 2007. Integrating molecular and network biology to decode endocytosis. Nature, 448(7156), 883–888.
   PubMed Web of Science ®Google Scholar
• Sharma, S., et al., 2013. Preliminary studies on the development of IgA-loaded chitosan-dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens. Journal of microencapsulation, 30(3), 283–294.
   PubMed Web of Science ®Google Scholar
• Shukla, B., Singh, B., and Katare, O.P., 2011. Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes. British journal of pharmacology, 164(2b), 820–827.
   PubMed Web of Science ®Google Scholar
• Silva, A.L., et al., 2013a. Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation. European journal of pharmaceutics and biopharmaceutics, 83(3), 338–345.
   PubMed Web of Science ®Google Scholar
• Silva, J.M., et al., 2013b. Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of controlled release, 168(2), 179–199.
   PubMed Web of Science ®Google Scholar
• Stowell, M.H., et al., 1999. Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nature cell biology, 1(1), 27–32.
   PubMed Web of Science ®Google Scholar
• Turk, C.T., et al., 2014. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. AAPS pharmscitech, 15(1), 161–176.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., et al., 2010. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. Journal of liposome research, 20(2), 97–104.
   PubMed Web of Science ®Google Scholar
• Vergati, M., et al., 2010. Strategies for cancer vaccine development. Journal of biomedicine and biotechnology, 2010, 1. Article ID: 596432.
   Google Scholar
• Yuan, F., et al., 2013. Wedelolactone inhibits LPS-induced pro-inflammation via NF-kappaB pathway in RAW 264.7 cells. Journal of biomedical science, 20(1), 84–94.
   PubMed Web of Science ®Google Scholar
• Zidan, A.S., et al., 2007. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. International journal of pharmaceutics, 332(1–2), 55–63.
   PubMed Web of Science ®Google Scholar